Alivus Life Sciences VIGYASA Scholarship Program
Alivus Life Sciences Limited
📌 About the Scholarship
The Alivus Life Sciences VIGYASA Scholarship Program 2025-26 is a scholarship initiative for Class 11 and Class 12 Science students from partnered schools under the Vigyasa Project. It aims to support meritorious students by offering financial assistance of up to INR 72,000 for education-related expenses. Alivus Life Sciences Limited, formerly Glenmark Life Sciences, is a pharmaceutical company focused on high-value Active Pharmaceutical Ingredients.
ℹ️ Event Details
- Program type: Scholarship program for school students.
- Mode of conduct: Online application through the Buddy4Study platform.
- Target students: Students studying in Class 11 or Class 12 Science.
- Eligible schools: Only students from partnered schools under the Vigyasa Project can apply.
- Scholarship amount: Selected students can receive up to INR 72,000
📅 Important Dates
- Application deadline: 1 June 2026.
- Application status: Open as of 25 May 2026, based on the listed deadline.
🎯 Eligibility & Rules
- Class requirement: Applicants must be studying in Class 11 or Class 12 Science.
- School requirement: Applicants must be from partnered schools under the Vigyasa Project.
- Academic requirement: Applicants must have scored at least 60% marks in the previous academic year.
- Family income limit: Annual parental income must not exceed INR 8 lakh from all sources.
- Application rule: Students should apply with correct academic, income and personal details through the online form.
- Evaluation process: Selection is expected to consider eligibility, academic merit, financial need and document verification
🏆 Prize Details and Value
- Scholarship benefit: Selected students can receive financial support of up to INR 72,000.
- Expense coverage: The scholarship may cover key education-related expenses such as institution fees, coaching fees, hostel/accommodation, food, transport and internet.
- Main incentive: Helps Science students continue education without financial pressure.